Monoclonal antibody therapy for pancreas cancer

Details Monoclonal antibody therapy for pancreas cancer Monoclonal antibody therapy for pancreas cancer

C - Chemistry, Metallurgy

12

N

C12N 15/13 (2006.01) A61K 39/395 (2006.01) A61P 35/00 (2006.01) C07K 16/18 (2006.01) C07K 16/30 (2006.01) C07K 16/46 (2006.01) C12P 21/02 (2006.01) G01N 33/574 (2006.01) G01N 33/58 (2006.01)

Patent

CA 2441042

The present invention relates to the use of binding equivalents of monoclonal antibody 31.1, including chimerized and/or humanized versions thereof, antibody fragments as well as competitively binding and co-specific antibodies and antibody fragments, in the treatment of pancreatic cancer.

La présente invention concerne l'utilisation d'équivalents liants de l'anticorps monoclonal 31.1, y compris de versions chimérisées et/ou humanisées dudit anticorps, de fragments d'anticorps ainsi que d'anticorps et fragments d'anticorps co-spécifiques et se liant de manière concurrentielle, dans le traitement du cancer du pancréas.

Affiliated with

Also associated with

Rating

Monoclonal antibody therapy for pancreas cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Monoclonal antibody therapy for pancreas cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibody therapy for pancreas cancer will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1702751